Join Anju at OCT Europe for Best Practices in Utilizing Decentralized Trials Technology

May 5-6, 2021 | Virtual Conference

Outsourcing in Clinical Trials Europe

The leading clinical outsourcing and operations conference in Europe is returning: the 11th OCT Europe edition will be hosted virtually on May 5-6, 2021, and Anju Software is proud to participate as a sponsor and speaker. Join our presentation or visit our virtual booth to learn about the latest and greatest practices in clinical trial design in these turbulent times for healthcare.

Utilizing Adaptive Systems to Get the Most from Decentralized Trials

How can you navigate your own challenges in this evolving clinical trial environment? Learn how harnessing technology and data will help your transition from traditional trials to hybrid and decentralized trials. Kim Rejndrup, Senior Vice President of Product Development at Anju Software, will be presenting jointly with Laura Acosta, Vice President of Product Management, eClinical Division, on “Utilizing Adaptive Systems to Get the Most from Decentralized Trials” on Wednesday, May 5 at 3:30 p.m. CET. More specifically, this presentation will share insights on:

  • How technology can assist you with country and site selection, and investigator strategy
  • How to gain a complete view of your trials from multiple data sources
  • How to design a hybrid monitoring strategy
  • How technology can reduce study set-up time
  • How to minimize cost and disruption during mid-study protocol amendments
  • How to automate generation of SDTM data

Register and Join Us

We would also welcome the opportunity to meet with you at our virtual booth for a conversation about Anju Software’s adaptive, easy to use, eClinical solutions suite that can help support the continued growth of your clinical pipeline, as we have done for other life science companies delivering life-saving therapies to patients around the world.

We look forward to seeing you at this year’s OCT Europe. Register here.

Want to stay up to date with our news?

To top